---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-22-040385"
form_type: "8-K"
ticker: "INM"
cik: "0001728328"
company_name: "InMed Pharmaceuticals Inc."
filed_at: "2022-07-20T23:59:59+00:00"
generated_at: "2026-06-24T11:25:50.162684+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.4
calibrated_materiality_score: 0.4
confidence: "high"
source: SEC EDGAR
---

# InMed appoints Michael Woudenberg as COO effective July 15, 2022

## Summary
- Michael Woudenberg appointed Chief Operating Officer, effective July 15, 2022.
- Previously served as SVP of Chemistry, Manufacturing and Controls.
- Employment agreement provides C$300,000 annual base salary.
- Eligible for annual discretionary bonus targeted at 40% of base salary.
- Woudenberg has over 20 years of drug development and GMP manufacturing experience.

## SEC filing metadata
- accession: 0001213900-22-040385
- form_type: 8-K
- ticker: INM
- cik: 0001728328
- company_name: InMed Pharmaceuticals Inc.
- filed_at: 2022-07-20T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.4
- calibrated_materiality_score: 0.4
- confidence: high
- sec_items: 5.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1728328/000121390022040385/0001213900-22-040385-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1728328/000121390022040385/ea163069-8k_inmedpharma.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-22-040385
- JSON: https://secwatch.observer/filing/0001213900-22-040385.json
- Plain text: https://secwatch.observer/filing/0001213900-22-040385.txt

## Key facts
- Executive change
  Michael Woudenberg was appointed as Chief Operating Officer at InMed Pharmaceuticals Inc..
  - Action: appointed
  - Role: Chief Operating Officer
  source text: On July 18, 2022, InMed Pharmaceuticals Inc. (the “Company”) issued a press release to announce that it has appointed Mr. Michael Woudenberg as the Company’s Chief Operating Officer effective July 15, 2022 (the “Effective Date”).
  evidence_url: https://www.sec.gov/Archives/edgar/data/1728328/000121390022040385/0001213900-22-040385-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.